To provide some balance, negatives I can see:
1.) Company is running out of cash due to lower profits and that profits are largely paper based (accounting treatments, R&D offsets etc.) meaning less free cash flow.
2.) Banks not prepared to loan money to the company (and they must be close to breaching any loan covenants they have in place currently). Clearly, borrowing the money to pay Intergen at current interest rates would have been a more financially sound option.
3.) No CEO in his / her right mind would issues shares at a discount unless they really had to.
What is interesting is that Intergen must have exceeded the hurdles that were set. Given that the recent announcement was about disappointing results from that part of the business, were the performance criteria set too low?
- Forums
- ASX - By Stock
- EPD
- Ann: Deferral of Intergen vendor payments and Appendix 3B
Ann: Deferral of Intergen vendor payments and Appendix 3B, page-3
-
- There are more pages in this discussion • 9 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add EPD (ASX) to my watchlist
Currently unlisted public company.
The Watchlist
CCO
THE CALMER CO INTERNATIONAL LIMITED
Anthony Noble, CEO
Anthony Noble
CEO
SPONSORED BY The Market Online